School of Nursing | HNH Fitness | Villa Marie Claire | Simulation Learning | About Holy Name | Careers | Ways to Give

Medical Care


Patients & Visitors




About Holy Name Medical Center About Holy Name Medical Center

Key Phone Numbers

  • Medical Center Operator

  • 201-833-3000

  • Physician Referral Service

  • 877-HOLY-NAME (465-9626)

  • Patient Information

  • 201-833-3300

  • Foundation (Donations)

  • 201-833-3187

  • Human Resources

  • 201-833-7040

  • Medical Staff Office

  • 201-833-3352

View All Department Contact Numbers

For general questions or comments, email info@holyname.org


For More Information:

201-227-6200
Gynecologic Oncology

gynonc@holyname.org

Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery

Surgical site infections (SSIs) can lead to substantial morbidity, prolonged hospitalization, increased costs, and death in patients undergoing colorectal procedures. We sought to investigate the effect of using an SSI reduction bundle on the rate of SSIs in gynecologic cancer patients undergoing colon surgery.

Continue Reading

Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping

The aim of this study was to determine progression-free survival (PFS) in patients with serous uterine carcinoma undergoing sentinel lymph node (SLN) mapping compared with patients undergoing standard lymphadenectomy.

Continue Reading

Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer

To compare the incidence of trocar site hernia in women who underwent robotically assisted laparoscopic surgery (RBT) for endometrial cancer staging with the incidence of ventral hernia formation in patients who underwent laparotomy (LAP) for the same indication. To analyze risk factors for hernia formation in women undergoing RBT for endometrial cancer.

Continue Reading

Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping

This study was designed to evaluate the outcome of patients with uterine carcinosarcoma undergoing sentinel lymph node (SLN).

Continue Reading